Catalyst Pharmaceuticals Inc (CN2 F) stock market data APIs
€26.0719
0(0%)
as of May 7, 2026
Try our APIs with
free plan!
Catalyst Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Prev. Close
26.0719
Open
26.0719
High
26.0719
Low
26.0719
52 wk Range
16.15-26.2
Market Cap
3 169 M
P/E Ratio
17.9861
Shares Outstanding
122 M
Revenue
589 M
Beta
0.718
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Catalyst Pharmaceuticals Inc data using free add-ons & libraries
Get Catalyst Pharmaceuticals Inc Fundamental Data
Catalyst Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 589 M
- EBITDA: 296 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Catalyst Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-11
- EPS/Forecast: 0.64
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Catalyst Pharmaceuticals Inc News
New
Angelini Interest Puts Catalyst Pharmaceuticals Rare Disease Value In Focus
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Angelini Pharma is reported to be evaluating a possible bid...
Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards?
Catalyst Pharmaceuticals CPRX is expected to beat estimates when it reports its first-quarter 2026 earnings results on May 11, after market close. The Zacks Consensus Estimate for CPRX’s earnings ...
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. What Catalyst Pharmaceuticals stock’s recent move may mea...
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
Catalyst Pharmaceuticals, Inc. The Company will Host a Conference Call and Webcast on May 12, 2026, at 8:30 AM ET CORAL GABLES, Fla., April 28, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc...
Get Catalyst Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
